These stocks are likely to be in focus on January 31
On Friday, the frontline equity indices, i.e., Sensex and Nifty were seen taking a path of recovery with Nifty regaining and the 17,000-level mark.
At close, the Sensex was down by 76.71 points or 0.13% at 57,200.23 and the Nifty was down by 8.20 points or 0.05% at 17,101.95.
On the BSE, about 1988 shares have advanced, 1365 shares declined, and 105 shares are unchanged.
These stocks are likely to be in focus for Monday's trading session –
Bharti Airtel Limited: Bharti Airtel has announced a partnership with Google, where the internet giant will invest up to US$ 1 billion as part of its Google for India Digitization Fund. The deal includes an investment of US$ 700 million to acquire 1.28%* ownership in Airtel and up to US$ 300 million toward potential multi-year commercial agreements. The partnership will focus on enabling affordable access to smartphones across price ranges and will continue to explore building on their existing partnerships to potentially co-create India-specific network domain use cases for 5G and other standards, and help accelerate the cloud ecosystem for businesses across India. The scrip was up by 1.23% at Rs 715.90, at market close, on Friday.
Larsen & Toubro Limited: L&T Hydrocarbon Engineering Limited (LTHE), a wholly-owned subsidiary of Larsen & Toubro, has secured a contract from Oil & Natural Gas Corporation (ONGC) for the seventh development phase of their Pipeline Replacement Projects (PRP-VII).
The EPCIC contract involves Engineering, Procurement, Construction, Installation and Commissioning of 350 km subsea pipelines and related offshore works spread out across India’s west coast offshore fields of ONGC. This contract, awarded through international competitive bidding, reposes ONGC’s confidence in LTHE’s capabilities and commitment to support ONGC in the strategic Oil & Gas Sector, and contribute to India’s energy security. The shares of L&T were at Rs 1898.80, down by 0.65% on the BSE, on Friday.
Dr Reddy’s Laboratories Limited: The drug manufacturing company reported a consolidated net profit of Rs 706.50 crore in Q3 December 2021, steeply higher than Rs 19.80 crore in Q3 December 2020. On a consolidated basis, the company's revenue from operations rose 7.91% to Rs 5319.70 crore in Q3 December 2021 over Q3 December 2020. Profit before tax soared 242% year-on-year to Rs 970.90 crore in Q3 December 2021. During the quarter, EBITDA was reported at Rs 1265.90 crore (up 6.82% YoY). The EBITDA margin stood 23.8% in Q3 December 2021 higher than 24% in Q3 December 2020 and 27% in Q2 September 2021. The scrip of the company was down by 0.90% at Rs 4217.85 at market close.
52-week high stocks – From the BSE 500 pack, the stocks of TV 18 Broadcast, ONGC, Bharat Dynamics, RHI Magnesita NV, Lakshmi Machine Works also have hit their 52-week high on Friday.
Start Investing in 5 mins*
Rs. 20 Flat Per Order | 0% Brokerage
About the Author
Open Free Demat Account
By proceeding, you agree to the T&C.
Fill in your details below: